Table 2.
aGenomic location | Reference/Variant 3′-5′ (5′-3′) |
European | Commercial | Pirbright | Indigenous | Amino acid change (5′-3′) | Codon | Exon | ||
---|---|---|---|---|---|---|---|---|---|---|
IFITM1 | SNVs | |||||||||
13,141 | G/A (C/T) | √ | √ | x | x | CGG to TGG | Arg to Trp | 77 | 2 | |
14,105 | C/T (G/A) | √ | x | x | x | TCG to TCA | Ser to Ser | 56 | 1 | |
IFITM2 | SNVs | |||||||||
14,960 | G/T (C/A) | √ | √ | √ | √ | CGG to AGG | Arg to Arg | 111 | 2 | |
15,078 | G/A (C/T) | x | x | x | √ | GGC to GGT | Gly to Gly | 72 | 2 | |
15,080 | C/T (G/A) | x | √ | x | √ | GGC to AGC | Gly to Ser | 72 | 2 | |
15,081 | T/C (A/G) | √ | √ | √ | √ | GTA to GTG | Val to Val | 71 | 2 | |
15,083 | C/T (G/A) | x | √ | x | x | GTA to ATA | Val to Ile | 71 | 2 | |
15,084 | G/A (C/T) | x | x | x | √ | TTC to TTT | Phe to Phe | 70 | 2 | |
16,175 | A/C (T/G) | √ | √ | √ | √ | GCT to GCG | Ala to Ala | 54 | 1 | |
16,193 | G/A (C/T) | x | x | x | √ | TTC to TTT | Phe to Phe | 48 | 1 | |
16,242 | T/C (A/G) | x | √ | x | √ | AAG to AGG | Lys to Arg | 32 | 1 | |
16,292 | G/A (C/T) | x | √ | x | x | TAC to TAT | Tyr to Tyr | 15 | 1 | |
16,295 | G/A (C/T) | √ | √ | √ | √ | TCC to TCT | Ser to Ser | 14 | 1 | |
16,303 | T/C (A/G) | x | x | x | √ | ATG to GTG | Met to Val | 12 | 1 | |
INDELs | ||||||||||
16,243–16,244 | TG/T (CA/A) | x | x | x | √ | Frameshift | 31 | 1 | ||
16,269 | A/ACC (T/GGT) | x | x | x | √ | Frameshift | 23 | 1 | ||
IFITM3 | SNVs | |||||||||
18,814 | T/C (A/G) | √ | x | x | x | ATG to GAG | Met to Glu | 119 | 2 | |
18,862 | C/T (G/A) | √ | √ | √ | √ | GTC to ATC | Val to Ile | 103 | 2 | |
19,572 | G/A (C/T) | x | x | x | √ | TGC to TGA | Cys to STOP | 59 | 1 | |
INDELs | ||||||||||
19,576–19,577 | AC/A (GT/T) | x | x | x | √ | Frameshift | 58 | 1 |
a These locations refer to the position on the PacBio consensus reference sequence already published and submitted [5]